NCT05537844 2022-09-23
BriTROC-2
Cancer Research UK, Glasgow
Unknown
Clinical Trials
4 trialsNCT05265793 2022-03-04
Camrelizumab Combined With Apatinib in the Treatment of Advanced Sarcomatoid Carcinoma or Carcinosarcoma
Fudan University
Phase 2 Unknown
NCT03570437 2022-03-02
COPELIA
University of Manchester
Phase 2 Unknown
NCT05224999 2022-02-04
Nivolumab for Recurrent/Metastatic Carcinosarcoma
Yonsei University
Phase 2 Unknown